| 000 | 01851 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515204241.0 | ||
| 264 | 0 | _c20100615 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1465-3621 | ||
| 024 | 7 |
_a10.1093/jjco/hyp200 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAmagai, Yosuke | |
| 245 | 0 | 0 |
_aCombination therapy of interleukin-2 and sorafenib improves survival benefits and prevents spontaneous pulmonary metastasis in murine renal cell carcinoma models. _h[electronic resource] |
| 260 |
_bJapanese journal of clinical oncology _cJun 2010 |
||
| 300 |
_a503-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBenzenesulfonates _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aInterleukin-2 _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aLung Neoplasms _xmortality |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 |
_aPyridines _xadministration & dosage |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aMatsumoto, Mitsunobu | |
| 700 | 1 | _aHojo, Kanji | |
| 700 | 1 | _aIguchi, Motofumi | |
| 700 | 1 | _aWada, Tooru | |
| 700 | 1 | _aTanaka, Hidekazu | |
| 700 | 1 | _aIde, Nobuyuki | |
| 700 | 1 | _aKato, Akira | |
| 700 | 1 | _aShichijo, Michitaka | |
| 700 | 1 | _aAbe, Kenji | |
| 773 | 0 |
_tJapanese journal of clinical oncology _gvol. 40 _gno. 6 _gp. 503-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jjco/hyp200 _zAvailable from publisher's website |
| 999 |
_c19481909 _d19481909 |
||